Plenty of exciting developments have taken place at EnWave Corporation (TSXV:ENW – $1.04 CAD & OTC:NWVCF – $0.82 USD & Frankfurt:E4U – €0.67) since our previous interview, so we are very pleased to sit down with Mr. Brent Charleton, the Senior Vice President of Sales and Business Development, to give us an update.
A substantial portion of the interview is devoted to the recent agreement that EnWave closed with a major Canadian cannabis player. Mr. Charleton first explains why EnWave’s REV technology is a game changer for the cannabis industry, and he goes on to say how the Company can benefit from this unique opportunity. Moreover, he shares his outlook in terms of machine sales and potential royalties for EnWave in this industry.
The interview also takes a look at the developments at NutraDried since it was reorganized, early 2017. Mr. Charleton reveals what the plans and targets are for the Moon Cheese manufacturer in 2018. In addition, he discusses the margins of the lower-priced ten ounce packages that are available at CostCo as of this month.
Investors also get valuable updates on the upgrade of the 120kW REV machine at Bonduelle as well as the machines that are being constructed for Sutro Biopharma and Merck.
Mr. Charleton furthermore describes why he is excited about EnWave’s contract with the US Army Natick Soldier R&D Center to jointly develop low weight, high quality, nutritious field rations. He gives an update on the very positive progresses so far.
Finally, the interview divulges ample information about 2018. We find out about new royalty streams that will come online, the number of potential machine sales in the pipeline, and the expected financial results for next year.
Access our interview by clicking the play button on the media player below, or download our convenient transcript.
Da EnWave auch in Deutschland eine große Anhängerschaft hat, haben wir das Transkript auf Deutsch übersetzt.
|Smallcaps.us Advice: Buy||Price Target: $3.41||Latest Company Report (pdf)|
|For important disclosures, please read our disclaimer.|